24 May 2013
Keywords: bayer, did, withhold, trasylol, safety, data, independent
Article | 03 September 2007
An independent review of the actions of Germany's Bayer AG regarding the surgical clotting agent Trasylol (aprotinin injection) has concluded
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 September 2007
23 May 2013
© 2013 thepharmaletter.com